Systemic inflammation modulates the ability of serum ferritin to predict all-cause and cardiovascular mortality in peritoneal dialysis patients
Open Access
- 23 June 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Nephrology
- Vol. 21 (1), 1-9
- https://doi.org/10.1186/s12882-020-01892-9
Abstract
Background This study aimed to ascertain whether the correlation of high serum ferritin with mortality is affected by systemic inflammation and to investigate the optimal serum ferritin level for predicting death when inflammation is considered in peritoneal dialysis (PD) patients. Methods We classified 221 patients into four groups according to serum ferritin concentration (100 mu g/L) and high-sensitivity CRP (hs-CRP) level (3 mg/L), and followed them regularly from the date of catheterization to Dec 31, 2016, at Sun Yat-Sen Memorial Hospital, China. Clinical and biochemical data were collected at baseline, and clinical outcomes such as all-cause and cardiovascular mortality were assessed. Results During a median follow-up of 35 months (3 similar to 109 months), 50 (22.6%) deaths occurred. Cardiovascular disease (46.0%) was the most common cause of death, followed by infection (10.0%). The Kaplan-Meier survival analysis and log-rank test revealed significantly worse survival accumulation among PD patients with higher serum ferritin (>= 100 mu g/L) under elevated hsCRP levels (> 3 mg/L) (P = 0.022). A multivariate Cox regression analysis revealed that an increased serum ferritin level was independently associated with a higher risk of all-cause and cardiovascular mortality in PD patients (HR = 3.114,P = 0.021; and HR = 9.382,P = 0.032) with hsCRP above 3 mg/L after adjusting for relevant confounding factors. Conclusion Higher serum ferritin levels were associated with an increased risk of all-cause and cardiovascular mortality in patients undergoing PD only in the presence of elevated hsCRP levels. The correlation of serum ferritin with poor outcome should take into consideration systemic inflammation.Funding Information
- Young Scientists Fund (81800595)
This publication has 35 references indexed in Scilit:
- Association of hsCRP, White Blood Cell Count and Ferritin with Renal Outcome in Chronic Kidney Disease PatientsPLOS ONE, 2012
- Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort studyKidney International, 2011
- Pathological Role of Aminolevulinate in Uremic PatientsTherapeutic Apheresis and Dialysis, 2011
- Inflammation in End-Stage Renal Disease-What Have We Learned in 10 Years?Seminars in Dialysis, 2010
- 2008 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney DiseaseTherapeutic Apheresis and Dialysis, 2010
- Persistent Inflammation as a Catalyst for Other Risk Factors in Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2009
- Iron Sequestration and Anemia of InflammationSeminars in Hematology, 2009
- Association of Markers of Iron Stores with Outcomes in Patients with Nondialysis-Dependent Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2009
- ForewordAmerican Journal of Kidney Diseases, 2006
- 2004 Japanese Society for Dialysis Therapy Guidelines for Renal Anemia in Chronic Hemodialysis Patients*Therapeutic Apheresis and Dialysis, 2004